Enliven Therapeutics shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $19M | 947k | 20.47 |
| 2025-06-30 | $9.3M | 463k | 20.06 |